Veris Residential (VRE) came out with quarterly funds from operations (FFO) of $0.2 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to FFO of $0.17 per share a year ago. These figures are adjusted for non-recurring items. This quarterly …
Company announces sale of South Mansfield upstream assets to JERA and strategic partnership with Woodside Energy to advance Louisiana pipeline and LNG projects TULSA, Okla., October 22, 2025--(BUSINESS WIRE)--Williams (NYSE: WMB) announced today a series of transactions that strengthens the company’s wellhead to water …
Thinking about what to do with Westgold Resources stock right now? You are not alone. With the share price surging more than 77.9% year-to-date and boasting a breathtaking 545.4% gain over three years, it has probably caught your eye, whether you are an investor …
Thinking about what to do with Macquarie Group stock? You are not alone. Whether you are tempted by its long-term growth track record or pondering if now is the moment to jump in, recent price action offers plenty to talk about. In just the …
Vancouver, BC, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSX-V: ROCK) (OTCQB:TRDTF) (“Trident” or the “Company” or the “Optionee”) is pleased to announce that it has signed a Property Option Agreement dated October 21, 2025 (the “Agreement”) with Edge Geological Consulting Inc.(“Edge” …
Fortescue's (ASX:FMG) stock up by 7.2% over the past three months. As most would know, long-term fundamentals have a strong correlation with market price movements, so we decided to look at the company's key financial indicators today to determine if they have any role …
The Australian market experienced a sell-heavy session recently, largely influenced by a dip in gold prices and profit-taking activities, though optimism surrounding US economic policies has also been noted. Amid these fluctuations, investors often seek out opportunities in less conventional areas such as penny …
MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that it has dosed the first patient in a Phase 1 clinical trial of TLX090 (153Samarium (Sm)-DOTMP), a therapeutic radiopharmaceutical candidate for treating pain associated …
The Australian market has recently experienced a sell-heavy session, influenced by profit-taking and shifts in global economic sentiment, particularly around gold prices and US relations. In such an environment, dividend stocks can provide a stable income stream for investors seeking to weather market fluctuations, …
As the Australian market experiences fluctuations driven by profit-taking and shifts in global economic sentiment, investors are closely watching sectors like Materials and Energy for opportunities. In this environment, identifying stocks that may be trading below their estimated value can be crucial for those …